ANI Pharmaceuticals to Present at Upcoming Investor Conferences
ANI Pharmaceuticals (NASDAQ:ANIP) has announced its participation in two upcoming investor conferences. CEO Nikhil Lalwani and the executive team will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 9:00 AM ET, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 1:50 PM ET.
Investors can access both live and archived webcasts through the company's website at www.anipharmaceuticals.com in the Investors section under Events and Presentations. The webcast replays will remain available for 90 days.
ANI Pharmaceuticals (NASDAQ:ANIP) ha annunciato la partecipazione a due prossimi convegni per investitori. L'amministratore delegato Nikhil Lalwani e il team esecutivo presenteranno al H.C. Wainwright 27th Annual Global Investment Conference l'8 settembre 2025 alle 9:00 ET e al Morgan Stanley 23rd Annual Global Healthcare Conference il 9 settembre 2025 alle 13:50 ET.
Gli investitori potranno seguire entrambe le presentazioni in diretta o on demand tramite il sito web della società all'indirizzo www.anipharmaceuticals.com, nella sezione Investors, sotto Events and Presentations. Le registrazioni delle webcast saranno disponibili per 90 giorni.
ANI Pharmaceuticals (NASDAQ:ANIP) ha anunciado su participación en dos próximas conferencias para inversores. El consejero delegado Nikhil Lalwani y el equipo ejecutivo presentarán en la H.C. Wainwright 27th Annual Global Investment Conference el 8 de septiembre de 2025 a las 9:00 ET y en la Morgan Stanley 23rd Annual Global Healthcare Conference el 9 de septiembre de 2025 a las 13:50 ET.
Los inversores podrán acceder a las retransmisiones en directo y a los archivos de las webcast a través del sitio web de la compañía en www.anipharmaceuticals.com, en la sección Investors, bajo Events and Presentations. Las repeticiones de las webcast permanecerán disponibles durante 90 días.
ANI Pharmaceuticals (NASDAQ:ANIP)가 다가오는 두 건의 투자자 컨퍼런스 참가를 발표했습니다. 최고경영자 니킬 랄와니(Nikhil Lalwani)와 경영진이 H.C. Wainwright 27th Annual Global Investment Conference에 2025년 9월 8일 오전 9:00(ET)에, Morgan Stanley 23rd Annual Global Healthcare Conference에 2025년 9월 9일 오후 1:50(ET)에 발표할 예정입니다.
투자자들은 회사 웹사이트 www.anipharmaceuticals.com의 Investors 섹션 내 Events and Presentations에서 두 이벤트의 라이브 및 아카이브 웹캐스트에 접속할 수 있습니다. 웹캐스트 다시보기는 90일 동안 제공됩니다.
ANI Pharmaceuticals (NASDAQ:ANIP) a annoncé sa participation à deux prochaines conférences investisseurs. Le PDG Nikhil Lalwani et l'équipe dirigeante présenteront lors de la H.C. Wainwright 27th Annual Global Investment Conference le 8 septembre 2025 à 9h00 ET, et lors de la Morgan Stanley 23rd Annual Global Healthcare Conference le 9 septembre 2025 à 13h50 ET.
Les investisseurs pourront accéder aux webcasts en direct et aux archives via le site internet de la société à l'adresse www.anipharmaceuticals.com, dans la rubrique Investors, sous Events and Presentations. Les replays des webcasts resteront disponibles pendant 90 jours.
ANI Pharmaceuticals (NASDAQ:ANIP) hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. CEO Nikhil Lalwani und das Führungsteam werden am H.C. Wainwright 27th Annual Global Investment Conference am 8. September 2025 um 9:00 Uhr ET sowie am Morgan Stanley 23rd Annual Global Healthcare Conference am 9. September 2025 um 13:50 Uhr ET präsentieren.
Investoren können beide Live-Übertragungen und die Archivaufzeichnungen über die Firmenwebsite www.anipharmaceuticals.com in der Rubrik Investors unter Events and Presentations ansehen. Die Webcast-Wiederholungen stehen für 90 Tage zur Verfügung.
- None.
- None.
PRINCETON, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team will present at two upcoming investor conferences as follows:
EVENT: H.C. Wainwright 27th Annual Global Investment Conference
DATE: Monday, September 8, 2025
TIME: 9:00am ET
EVENT: Morgan Stanley 23rd Annual Global Healthcare Conference
DATE: Tuesday, September 9, 2025
TIME: 1:50pm ET
The live and archived webcasts will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit www.anipharmaceuticals.com.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) presenting at the H.C. Wainwright Conference 2025?
When is ANI Pharmaceuticals (ANIP) presenting at the Morgan Stanley Healthcare Conference 2025?
Who will be presenting at the upcoming ANI Pharmaceuticals investor conferences?
How can investors access ANI Pharmaceuticals' conference presentations?
